LOS ALTOS, Calif., Oct. 4, 2013 /PRNewswire-iReach/ -- Boreal Genomics, a privately held provider of technology for non-invasive genomic profiling of tumors from blood plasma of cancer patients, announced today the completion of an $18 million Series C financing round. The financing will......
More...